Market
Report / TASE rises as US smiles onHa'aretz, Israel - 12 hours
ago... Teva dropped 1 percent on Wall Street,
and started yesterday with a negative arbitrage
gap of 1.2 percent, despite
reporting FDA approval for generic Remeron. ...
Volumes
remain low on TASE
Globes
Online, Israel - 26 Jan 2003
... Teva announced on Friday that it received final FDA approval
to market Mirtazapine
tablets, the generic version of Organon’s
Remeron drug, which is used to ...
Teva
wins final FDA approval for generic Remeron
Globes Online, Israel - 26 Jan
2003
... The tablets are the generic version of
Akzo Nobel’s Remeron antidepressant,
and the brand versions generated
annual sales of $354 million, Teva said. ...
Teva
Announces Final Approval of Mirtazapine 15mg, 30mg; 180-Day ...
BusinessWire (press
release) - 24 Jan 2003
... the
US District Court for the District of New Jersey granting summary judgment
in
Teva's favor on the issue of non-infringement with regard to Organon's
Remeron ...
Inquest: Alcohol
played role in Mt. Pulaski fatality
Lincoln Courier, IL - 11 Jan
2003
... According to autopsy results, Carr died
from acute poisoning after accidentally
ingesting a combination of
Remeron, Darvon and alcohol. ...
Drugs
for the Elderly changes effective today
Central Maine Daily Sentinel, ME - 09 Jan
2003
... drugs and treatments including the
Efudex cream used by patients with pre-cancerous
skin lesions and
psychotropic drugs such as the antidepressant Remeron ...
Akzo
Nobel admits recovery hopes wrong
Financial Times (subscription), UK - 08 Jan
2003
... That followed an "unfortunate" drug
launch delay in the US and the loss of an
"important" court case to protect
its best-selling product Remeron, an anti ...
Changing
antidepressant could increase sex drive
West County Times, CA - 07 Jan
2003
... Nefazodone (Serzone) and mirtazapine
(Remeron) are other antidepressants
that reportedly are unlikely to
cause sexual dysfunction. ...
S&P
maintains 5-star rating on Teva
Globes
Online, Israel - 31 Dec 2002
... He also drew investors’ attention to Teva’s recent win of 180
days exclusivity
to market a generic version of Akzo Nobel NV's
Remeron antidepressant. ...
